Alpha 1-antitrypsin deficiency other diagnostic studies
|
Alpha 1-antitrypsin deficiency Microchapters |
|
Differentiating Alpha 1-antitrypsin deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Alpha 1-antitrypsin deficiency other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Alpha 1-antitrypsin deficiency other diagnostic studies |
|
FDA on Alpha 1-antitrypsin deficiency other diagnostic studies |
|
CDC on Alpha 1-antitrypsin deficiency other diagnostic studies |
|
Alpha 1-antitrypsin deficiency other diagnostic studies in the news |
|
Blogs on Alpha 1-antitrypsin deficiency other diagnostic studies |
|
Directions to Hospitals Treating Alpha 1-antitrypsin deficiency |
|
Risk calculators and risk factors for Alpha 1-antitrypsin deficiency other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Patients with low or borderline serum levels are tested with phenotyping (serum levels < 100 mg/dL) by isoelectric focusing (IEF) is the most commonly used method to definitively detect the alpha1-antitrypsin phenotype that indicates a risk for AATD. Genotyping uses DNA extracted from circulating mononuclear blood cells that utilizes DNA amplification techniques with melt-curve analysis.
Other Diagnostic Studies
Phenotyping
Patients with low or borderline serum levels are tested with phenotyping (serum levels < 100 mg/dL) by isoelectric focusing (IEF) is the most commonly used method to definitively detect the alpha1-antitrypsin phenotype that indicates a risk for AATD. [1][2]
Phenotyping is required to confirm AATD. Do not initiate alpha1-antitrypsin replacement therapy without testing.
PiZZ phenotype is responsible for nearly all cases of AATD emphysema and liver disease.
PiSZ and PiZ/Null are other phenotypes associated with alpha1-antitrypsin emphysema and liver disease.
PiNull/Null is not associated with liver disease but is associated with alpha1-antitrypsin deficiency emphysema.
Genotyping
Genotyping uses DNA extracted from circulating mononuclear blood cells that utilizes DNA amplification techniques with melt-curve analysis.
References
- ↑ Ljujic M, Topic A, Divac A, Nikolic A, Petrovic-Stanojevic N, Surlan M, Mitic-Milikic M, Radojkovic D (2008). "Isoelectric focusing phenotyping and denaturing gradient gel electrophoresis genotyping: a comparison of two methods in detection of alpha-1-antitrypsin variants". Transl Res. 151 (5): 255–9. doi:10.1016/j.trsl.2008.02.002. PMID 18433707.
- ↑ Al-Jameil N, Hassan AA, Buhairan A, Hassanato R, Isac SR, Al-Otaiby M, Al-Maarik B, Al-Ajeyan I (2017). "Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis". Medicine (Baltimore). 96 (6): e6071. doi:10.1097/MD.0000000000006071. PMC 5313019. PMID 28178162.